109 related articles for article (PubMed ID: 11905524)
21. Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolism.
Guichelaar MM; Malinchoc M; Sibonga J; Clarke BL; Hay JE
Liver Transpl; 2004 May; 10(5):638-47. PubMed ID: 15108255
[TBL] [Abstract][Full Text] [Related]
22. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
23. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.
Pichette V; Bonnardeaux A; Prudhomme L; Gagné M; Cardinal J; Ouimet D
Am J Kidney Dis; 1996 Jul; 28(1):105-14. PubMed ID: 8712204
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
[TBL] [Abstract][Full Text] [Related]
25. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
26. Lumbar bone mineral density in very long-term renal transplant recipients: impact of circulating sex hormones.
Brandenburg VM; Ketteler M; Heussen N; Politt D; Frank RD; Westenfeld R; Ittel TH; Floege J
Osteoporos Int; 2005 Dec; 16(12):1611-20. PubMed ID: 15999293
[TBL] [Abstract][Full Text] [Related]
27. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K
J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
[TBL] [Abstract][Full Text] [Related]
28. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF; Lodder MC; Lips P; Bijlsma JW; Geusens P; Schrameijer N; van de Ven CM; Dijkmans BA
Osteoporos Int; 2006; 17(5):716-23. PubMed ID: 16463007
[TBL] [Abstract][Full Text] [Related]
29. Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome.
Minetto M; Reimondo G; Osella G; Ventura M; Angeli A; Terzolo M
Osteoporos Int; 2004 Nov; 15(11):855-61. PubMed ID: 15034643
[TBL] [Abstract][Full Text] [Related]
30. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
Laway BA; Goswami R; Singh N; Gupta N; Seith A
Clin Endocrinol (Oxf); 2006 Apr; 64(4):405-9. PubMed ID: 16584512
[TBL] [Abstract][Full Text] [Related]
31. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.
Atamaz F; Hepguler S; Akyildiz M; Karasu Z; Kilic M
Osteoporos Int; 2006; 17(6):942-9. PubMed ID: 16550299
[TBL] [Abstract][Full Text] [Related]
32. Evidence of continuing bone recovery at a mean of 7 years after liver transplantation.
Feller RB; McDonald JA; Sherbon KJ; McCaughan GW
Liver Transpl Surg; 1999 Sep; 5(5):407-13. PubMed ID: 10477842
[TBL] [Abstract][Full Text] [Related]
33. Prospective randomized trial of steroid withdrawal in liver transplant patients: preliminary report.
Belli LS; De Carlis L; Rondinara GF; Romani F; Alberti A; Pirotta V; Sansalone CV; Riolo F; Rossetti O; Slim OA; Aseni P; Ideo G; Belli L
Transpl Int; 1994; 7 Suppl 1():S88-90. PubMed ID: 11271343
[TBL] [Abstract][Full Text] [Related]
34. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
35. The influence of corticosteroids on quantitative ultrasound parameters of the calcaneus in the 1st year after renal transplantation.
ter Meulen CG; Hilbrands LB; van den Bergh JP; Hermus AR; Hoitsma AJ
Osteoporos Int; 2005 Mar; 16(3):255-62. PubMed ID: 15232677
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of reduced bone mineral density in patients with anti-neutrophil cytoplasmic antibody associated vasculitis and the role of immunosuppressive therapy: a cross-sectional study.
Boomsma MM; Stegeman CA; Kramer AB; Karsijns M; Piers DA; Tervaert JW
Osteoporos Int; 2002 Jan; 13(1):74-82. PubMed ID: 11883409
[TBL] [Abstract][Full Text] [Related]
37. Bone status in glucocorticoid-treated men and women.
Leib ES; Winzenrieth R
Osteoporos Int; 2016 Jan; 27(1):39-48. PubMed ID: 26252975
[TBL] [Abstract][Full Text] [Related]
38. Bone metabolism in orthotopic liver transplantation: a prospective study.
Floreani A; Fries W; Luisetto G; Burra P; Fagiuoli S; Boccagni P; Della Rovere GR; Plebani M; Piccoli A; Naccarato R
Liver Transpl Surg; 1998 Jul; 4(4):311-9. PubMed ID: 9649646
[TBL] [Abstract][Full Text] [Related]
39. Decreased bone mineral density is common after autologous blood or marrow transplantation.
Schimmer AD; Mah K; Bordeleau L; Cheung A; Ali V; Falconer M; Trus M; Keating A
Bone Marrow Transplant; 2001 Aug; 28(4):387-91. PubMed ID: 11571512
[TBL] [Abstract][Full Text] [Related]
40. Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation.
Trautwein C; Possienke M; Schlitt HJ; Böker KH; Horn R; Raab R; Manns MP; Brabant G
Am J Gastroenterol; 2000 Sep; 95(9):2343-51. PubMed ID: 11007240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
